It is Pharma Time: Why Merck and Lilly Stock Are Buys, but not Pfizer.

January 9, 2023

My 2023 biotech outlook phone calls for ongoing momentum in identify alterations. I just have to have to determine out ...

It is Pharma Time: Why Merck and Lilly Stock Are Buys, but not Pfizer.

by souhaib

January 7, 2023

0

My 2023 biotech outlook calls for ongoing momentum in title variations. I just will need to determine out what the ...

Why Pfizer Is Pulling Back again on Exploration Into Unusual Condition, Gene Treatment

by souhaib

January 6, 2023

0

Pfizer is preparing to pull again on early-phase research into treatments for exceptional illnesses, which include the development of new ...

China’s ‘elite are stockpiling Pfizer’s Covid drug’ as place battles substantial wave of infections

by souhaib

December 29, 2022

0

China's abrupt lifting of many of its challenging pandemic constraints before this thirty day period has authorized the virus to unfold ...

6 Defensive Health care Stocks for 2023

by souhaib

December 22, 2022

0

As buyers confront another uncertain year for public equities, huge-cap health care stocks remain an beautiful defensive perform. They give ...

Pfizer and Moderna Shares Break Out. Here’s the Trade.

by souhaib

December 15, 2022

0

Drug stocks have been on fire lately, and over the past few weeks, the two leading covid-19 vaccine makers, Pfizer (PFE) - ...

Microsoft Tops the Finest-Managed Providers of 2022

by souhaib

December 12, 2022

0

Journal Studies: LeadershipHow the Administration Prime 250 Rankings Are PickedDecember 11, 2022 at 2:01 PM ETThe Drucker Institute’s methodology for ...

The 7 Companies That Do It All Well in the Rankings of Very best-Managed Organizations

by souhaib

December 11, 2022

0

Journal Stories: ManagementAmong the Very best-Managed Businesses of 2022, Some Warning SignsBy Chris KornelisDecember 11, 2022 at 2:08 PM ETThese ...